A. Le Mevel

705 citations
14 papers · 532 indexed · h-index 8
Topics
Lymphoma Diagnosis and Treatment (9 papers)Viral-associated cancers and disorders (6 papers)Lung Cancer Treatments and Mutations (4 papers)
Partner nations
France

In The Last Decade

A. Le Mevel

14 papers receiving 503 citations

Peers

A. Le Mevel
Comparison fields: 5 of 51
  • Pathology and Forensic Medicine 310
  • Neurology 265
  • Genetics 235
  • Oncology 159
  • Hematology 91
Replace Timothy L. Thar with:
Timothy L. Thar United States
Ferial Shihadeh United States
K.H. Liew Australia
Patrizia Albertini Italy
Joseph M. Connors Canada
Jane Myers United States
P. Gobbi Italy
J O Armitage United States
Paolo Gavarotti Italy
JR Redman United States
A. Le Mevel relative to Timothy L. Thar United States Timothy L. Thar's profile →
Citations per field
00.5×3.5×
Timothy L. Thar · 1×
Citations per year

Countries citing papers authored by A. Le Mevel

Since Specialization
Citations

This map shows the geographic impact of A. Le Mevel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Le Mevel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Le Mevel more than expected).

Fields of papers citing papers by A. Le Mevel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Le Mevel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Le Mevel. The network helps show where A. Le Mevel may publish in the future.

Co-authorship network of co-authors of A. Le Mevel

This figure shows the co-authorship network connecting the top 25 collaborators of A. Le Mevel. A scholar is included among the top collaborators of A. Le Mevel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Le Mevel. A. Le Mevel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 1
2 10
3 87
4 5
5
[Leukemia and pre-leukemic conditions occurring after treatment of breast cancer].
6
6 6
7 244
8 32
9
Is the International Prognostic Index for aggressive lymphomas useful for low-grade lymphoma patients? Applicability to stage III-IV patients. The GOELAMS Group, France.
19
10
Chromosome aberrations after radiotherapy in patients treated for non Hodgkin's lymphoma.
1
11 54
12 42
13 3
14 22

About A. Le Mevel

A. Le Mevel is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics, having authored 14 papers that have together received 532 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (9 papers), Viral-associated cancers and disorders (6 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Genetics (235 citations), Neurology (265 citations) and Pathology and Forensic Medicine (310 citations). A. Le Mevel has collaborated with scholars based in France. Frequent co-authors include Pierre Biron, Christine Chevreau, E Baumelou, Houchingue Eghbali, Franck Chauvin, Bertrand Coiffier, Jean‐Yves Blay, T. Conroy, Antoine Thyss and Nöel Milpied. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026